EFM
MGNX icon

E Fund Management’s MacroGenics MGNX Stock Holding History

E Fund Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,667
Closed -$245K – 351
2024
Q1 		$245K Buy
+16,667
New +$252K 0.02% 303
2022
Q2 		– Sell
-10,417
Closed -$92K – 340
2022
Q1 		$92K Buy
+10,417
New +$115K ﹤0.01% 317

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

E Fund Management's MGNX Position: Q2 2024 in Review

E Fund Management sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 16,667 shares — an estimated $245K sold.

E Fund Management first reported a position in MGNX in Q1 2022 and held it in 2 quarters. The position peaked at $245K in Q1 2024. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • E Fund Management reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • E Fund Management sold 16,667 MacroGenics shares in Q2 2024, an estimated $245K.
  • E Fund Management first reported a position in MacroGenics in Q1 2022 and held it in 2 quarters.
  • E Fund Management's MacroGenics position peaked at $245K in Q1 2024.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.